[1]CurrentPatentAssignee:BIOCRYSTPHARMACEUTICALSINC-WO2021/72156,2021,A1Locationinpatent:Page/Pagecolumn140-141
1026089-09-7
6056-23-1
1261878-59-4
205318-12-3
2169604-83-3
622797-04-0
126266-75-9 | 3,3-Dichloro-1,1,1-trifluoroacetone | AA00HRCV | MFCD04038304
1273566-32-7 | Rel-(3s,3as,6as)-5-(tert-butoxycarbonyl)hexahydro-2h-furo[2,3-c]pyrrole-3-carboxylic acid | AA00HRLY | MFCD18793342
130-40-5 | Riboflavin sodium phosphate | AA00HRXI | MFCD00065362
1312942-16-7 | (2-Isopropylpyrimidin-5-yl)boronic acid | AA00HSCC | MFCD10696941
1330286-53-7 | Z-Ser(trt)-oh | AA00HSNJ | MFCD02684513
1334499-78-3 | Cis-1-tert-butyl 4-methyl 3-methylpiperidine-1,4-dicarboxylate | AA00HSUO | MFCD20261477
1341035-71-9 | Methyl 5-hydroxy-3-methoxy-2-naphthoate | AA00HT3R | MFCD21362322
135006-32-5 | (But-3-en-1-yloxy)(tert-butyl)diphenylsilane | AA00HTRE | MFCD26523314
1354000-92-2 | (R)-2-Chloro-1-(3-methoxypyrrolidin-1-yl)ethanone | AA00HU21 | MFCD21092827
136022-04-3 | Tetradec-1-yn-3-ol | AA00HUCT | MFCD00185860